Compare
Nu Skin Enterprises, Inc. vs Herbalife Ltd. vs Cosmos Health Inc. vs Cardinal Health Inc
| Latest fiscal year | Nu Skin Enterprises, Inc. NUS | Herbalife Ltd. HLF | Cosmos Health Inc. COSM | Cardinal Health Inc CAH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-06-30 |
| Revenue | $1.49B | $5.04B | $65.27M | $254.25B |
| Revenue growth (YoY) | -14.3% | +0.9% | +19.9% | +14.2% |
| Gross margin | 69.4% | 77.9% | 12.1% | 3.8% |
| Operating margin | 4.4% | 9.5% | -25.6% | 1.0% |
| Net margin | 10.8% | 4.5% | -29.3% | 0.7% |
| Net income | $160.20M | $228.30M | -$19.14M | $1.71B |
| EPS (Diluted) | $3.18 | $2.20 | -$0.63 | $7.23 |
| Operating cash flow | $80.29M | $333.30M | -$8.45M | $5.17B |
| Free cash flow | $46.01M | $252.90M | -$8.50M | $4.53B |
| Cash & equivalents | $238.63M | $353.10M | $715.7K | $4.86B |
| Total assets | $1.41B | $2.79B | $65.48M | $57.30B |
| Total liabilities | $600.07M | $3.30B | $47.05M | n/a |
| Shareholders' equity | $805.24M | -$515.10M | $18.42M | -$2.88B |
| Return on year-end equity | 19.9% | n/a | -103.9% | n/a |
| Shares outstanding | n/a | 103.30M | 41.07M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Nu Skin Enterprises, Inc. | Herbalife Ltd. | Cosmos Health Inc. | Cardinal Health Inc |
|---|---|---|---|---|
| Latest | $1.49B Ended 2025-12-31 | $5.04B Ended 2025-12-31 | $65.27M Ended 2025-12-31 | $254.25B Ended 2026-06-30 |
| 1 year earlier | $1.73B Ended 2024-12-31 | $4.99B Ended 2024-12-31 | $54.43M Ended 2024-12-31 | $222.58B Ended 2025-06-30 |
| 2 years earlier | $1.97B Ended 2023-12-31 | $5.06B Ended 2023-12-31 | $53.38M Ended 2023-12-31 | $226.83B Ended 2024-06-30 |
| 3 years earlier | $2.23B Ended 2022-12-31 | $5.20B Ended 2022-12-31 | $50.35M Ended 2022-12-31 | $204.98B Ended 2023-06-30 |
| 4 years earlier | $2.70B Ended 2021-12-31 | $5.80B Ended 2021-12-31 | $56.24M Ended 2021-12-31 | $181.33B Ended 2022-06-30 |